JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 2, 2005; DOI: 10.1124/jpet.104.082420


0022-3565/05/3133-1239-1247$20.00
JPET 313:1239-1247, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.082420v1
313/3/1239    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tawfik, V. L.
Right arrow Articles by DeLeo, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tawfik, V. L.
Right arrow Articles by DeLeo, J. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MORPHINE
Medline Plus Health Information
*Pain

NEUROPHARMACOLOGY

Transcriptional and Translational Regulation of Glial Activation by Morphine in a Rodent Model of Neuropathic Pain

V. L. Tawfik, M. L. LaCroix-Fralish, N. Nutile-McMenemy, and J. A. DeLeo

Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire (V.L.T., M.L.L.-F., J.A.D.); and Department of Anesthesiology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire (N.N.-M., J.A.D.)

Glial cells function in maintenance of homeostasis as well as in pathophysiology. In this study, we determined the time course of spinal glial cell activation during the development of morphine analgesic tolerance in an L5 spinal nerve transection rodent model of neuropathic pain. We also sought to assess whether the method of morphine administration affected neuroimmune activation at the levels of transcription and translation. Rats received L5 spinal nerve transection or no surgery on day 0. On day 6 post-transection, osmotic minipumps were implanted to deliver saline or morphine s.c. (1 or 10 mg/kg) or i.t. (5 or 20 nmol/h). Mechanical allodynia developed immediately after spinal nerve transection; this hypersensitivity was reversed with both low- and high-dose morphine by either route. Tolerance to antiallodynia developed after 3 days of i.t. morphine and after 6 days of s.c. morphine, indicating hastened tolerance following i.t. delivery. Analysis of mRNA revealed that s.c. morphine treatment did not lead to increases in glial activation markers. In contrast, i.t. morphine caused a biphasic alteration in glial fibrillary acidic protein (GFAP) and integrin {alpha} M mRNA. Protein levels for GFAP were elevated after s.c. and i.t. administration of morphine; however, induction was further enhanced in the latter group. Here, we show for the first time that there is differential recruitment of transcriptional and translational mechanisms of glial activation by systemic and i.t. morphine. Furthermore, we suggest that enhanced neuroimmune activation after i.t. dosing contributes to the hastened development of analgesic tolerance seen in these animals.


Received for publication January 7, 2005
Accepted February 28, 2005.

Address correspondence to: Dr. Joyce A. DeLeo, 1 Medical Center Drive, Borwell 554E, Lebanon, NH 03756. E-mail: joyce.a.deleo{at}dartmouth.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
R. J. Horvath and J. A. DeLeo
Morphine Enhances Microglial Migration through Modulation of P2X4 Receptor Signaling
J. Neurosci., January 28, 2009; 29(4): 998 - 1005.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.